世衛和大藥廠官員可能被傳召參與歐洲議會聽證會

世衛和大藥廠官員可能被傳召參與歐洲的議會委員會聽證會
WHO and Big Pharma Officials To Be Summoned to Hearing At Council of Europe's Parliament

Thursday, 07 January 2010 13:12
News - Highlighted News

Is the mass vaccination campaign with the untested and toxic swine flu jab really a gigantic operation orchestrated with the complicity of governments by Big Pharma for profit?
用未經測試和有毒豬流感刺戳於大規模疫苗接種運動，是否真的是一個巨大的操作，為利潤由大藥公司策劃各國政府的串通關係呢？
This is going to be the issue investigated by the Council of European Parliamentary Assembly at the end of January after a motion was submitted by former SPD MP Wolfgang Wodarg, an epidemiologist and lung specialist.
在前社民黨議員Wolfgang Wodarg(一名流行病學家和肺專家)提交的一項議案後，這將是歐洲議會委員會1月底時要調查的議題。
Officials from the WHO as well as representatives from the pharmaceutical industry are set to appear at a hearing scheduled for January 28th, though the official green light for the hearing is not expected to come until Monday, January 25th, the first technical day of the parliamentary session, and attempts to strike these items from the agenda cannot be excluded.
世衛的官員及來自製藥業的代表，被定於1月28日出席聆訊，儘管聆訊的官方綠燈預計要等2009年1月25日星期一才有，決定於議會會期技術上的第一天，和企圖打擊這綠燈決定的議程不能排除。
Even Le Monde is carrying a report (see below) on the upcoming hearing.

„In order to promote their patented drugs and vaccines against flu, pharmaceutical companies have influenced scientists and official agencies, responsible for public health standards, to alarm governments worldwide. They have made them squander tight health care resources for inefficient vaccine strategies and needlessly exposed millions of healthy people to the risk of unknown side-effects of insufficiently tested vaccines,“ reads Wodarg’s motion, which has gained the support of 14 MPs so far.

In parallel, the Council of Europe’s influential health committee headed by Christine McCafferty, has also deposited a request for an „urgent debate“ on the swine flu vaccination campaign during the next parliamentary session due to take place between January 25th and 29th in Strasbourg, France.

But what power does the Council of Europe parliamentary assembly have to reign in WHO and the pharmaceutical companies?

Angus McDonald from the Council of Europe explained that the Council of Europe is separate from the European Union and the European Parliament - and also older, having been founded in 1949.

The Council of Europe is composed of members of parliament drawn from all 47 European states, including Russia, the Ukraine and Norway, among others.

It oversees the operation of the European Court of Human Rights as well as the European Pharmacopoeia, a body sets down legally binding quality standards for medicines and pharmaceutical products inside European countries.

Because the members of parliaments who attend the Council of Europe parliament assembly are also directly elected members of their own national parliaments, the Council of Europe can be considered a more democratic body and also to be more representative of the views of Europe’s 800 million citizens than the EU, argues McDonald.

MPS attending the Council of Europe sessions, held four times a year, can return to their own countries and initiate investigations or parliamentary inquiries there.

A debate at a Council of Europe parliamentary assembly sessions can conclude with either a resolution or a recommendation to European governments to undertake a specific course of action concerning, in this case, the handling of a pandemic.

But while the Council of Europe can highlight an issue, it has no binding leislative power to force governments to take action.

A Committee of Ministers made up of the foreign ministers of the 47 European countries is part of the Council of Europe. This body can compell governments to respond to assembly resolutions,

The hearing intiated by Wodarg is separate from the „urgent debate“ expected to be held as a result of the submission of Christine McCafferty, head of the health and family affairs committee. However, both these events could represent a significant blow to the big pharma lobby.

Information that emerges from these hearings and circulates widely among European elected representatives could result in demands for parliamentary inquiries among the parliamentary base that the big pharma and banks do not appear to control to the same extent as they appear to control the higher echelons of government and the EU.

In addition, the swine flu vaccine scandal might add to the widespread anger among European citizens over their governments and their handling of the financial crisis, with the banks coming out the winners while public services undergo cuts – and lead to pressure for more transparency among Europe’s governments.

http://veilleur.blog.lemonde.fr/2010/01/07/grippe-h1n1-le-conseil-de-leurope-veut-une-enquete/

07 janvier 2010

Grippe H1N1 : le Conseil de l’Europe veut une enquête

Alors que plusieurs pays européens commencent à revendre leurs surplus......

http://www.theflucase.com/index.php?option=com_content&view=article&id=2494%3Awho-and-big-pharma-officials-to-be-summoned-to-hearing-at-council-of-europes-parliament-&catid=41%3Ahighlighted-news&Itemid=105&lang=en